JP2014518630A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014518630A5 JP2014518630A5 JP2014513202A JP2014513202A JP2014518630A5 JP 2014518630 A5 JP2014518630 A5 JP 2014518630A5 JP 2014513202 A JP2014513202 A JP 2014513202A JP 2014513202 A JP2014513202 A JP 2014513202A JP 2014518630 A5 JP2014518630 A5 JP 2014518630A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- human
- sequence
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 102000040430 polynucleotide Human genes 0.000 claims 4
- 108091033319 polynucleotide Proteins 0.000 claims 4
- 239000002157 polynucleotide Substances 0.000 claims 4
- 208000023275 Autoimmune disease Diseases 0.000 claims 3
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 3
- 101000980814 Homo sapiens CAMPATH-1 antigen Proteins 0.000 claims 3
- 201000002481 Myositis Diseases 0.000 claims 3
- 206010052779 Transplant rejections Diseases 0.000 claims 3
- 206010047115 Vasculitis Diseases 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 208000024908 graft versus host disease Diseases 0.000 claims 3
- 102000043738 human CD52 Human genes 0.000 claims 3
- 208000032839 leukemia Diseases 0.000 claims 3
- 201000006417 multiple sclerosis Diseases 0.000 claims 3
- 210000000056 organ Anatomy 0.000 claims 3
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 3
- 230000005867 T cell response Effects 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 claims 1
- 102000006354 HLA-DR Antigens Human genes 0.000 claims 1
- 108010058597 HLA-DR Antigens Proteins 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 210000002443 helper t lymphocyte Anatomy 0.000 claims 1
- 230000006698 induction Effects 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 210000001236 prokaryotic cell Anatomy 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161492005P | 2011-06-01 | 2011-06-01 | |
| US61/492,005 | 2011-06-01 | ||
| GB1109238.4 | 2011-06-01 | ||
| GBGB1109238.4A GB201109238D0 (en) | 2011-06-01 | 2011-06-01 | Antibodies |
| PCT/EP2012/060345 WO2012164063A1 (en) | 2011-06-01 | 2012-06-01 | Humanised anti-cd52 antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014518630A JP2014518630A (ja) | 2014-08-07 |
| JP2014518630A5 true JP2014518630A5 (enExample) | 2015-07-16 |
| JP6254522B2 JP6254522B2 (ja) | 2017-12-27 |
Family
ID=44310746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014513202A Active JP6254522B2 (ja) | 2011-06-01 | 2012-06-01 | ヒト化抗ｃｄ５２抗体 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9321841B2 (enExample) |
| EP (1) | EP2714739A1 (enExample) |
| JP (1) | JP6254522B2 (enExample) |
| KR (1) | KR20140036274A (enExample) |
| CN (1) | CN103649122B (enExample) |
| AU (1) | AU2012264643B2 (enExample) |
| BR (1) | BR112013030875A2 (enExample) |
| CA (1) | CA2837965A1 (enExample) |
| GB (1) | GB201109238D0 (enExample) |
| IL (1) | IL229713A (enExample) |
| MX (1) | MX342676B (enExample) |
| MY (1) | MY163257A (enExample) |
| RU (1) | RU2605307C2 (enExample) |
| SG (1) | SG195042A1 (enExample) |
| WO (1) | WO2012164063A1 (enExample) |
| ZA (1) | ZA201308900B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2011012047A (es) | 2009-05-13 | 2011-12-14 | Genzyme Corp | Inmunoglobulinas humanas anti-cd52. |
| WO2014165271A2 (en) | 2013-03-13 | 2014-10-09 | Neotope Biosciences Limited | Tau immunotherapy |
| EP3452507B1 (en) | 2016-05-02 | 2022-10-19 | Prothena Biosciences Limited | Tau immunotherapy |
| MX2018013384A (es) | 2016-05-02 | 2019-02-28 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau. |
| US10906964B2 (en) | 2016-05-02 | 2021-02-02 | Prothena Biosciences Limited | Antibodies recognizing tau |
| CN106018814B (zh) * | 2016-08-07 | 2017-11-14 | 深圳市南海生物科技有限公司 | 一种用于白血病和自身免疫病检测用试剂盒 |
| TW201841653A (zh) * | 2017-04-21 | 2018-12-01 | 美商建新公司 | 以抗-cd52抗體治療多發性硬化症 |
| SG11201910066QA (en) | 2017-05-02 | 2019-11-28 | Prothena Biosciences Ltd | Antibodies recognizing tau |
| MX2020011552A (es) | 2018-05-03 | 2020-11-24 | Genmab Bv | Combinaciones de variantes de anticuerpos y usos de las mismas. |
| TWI859197B (zh) | 2019-03-03 | 2024-10-21 | 愛爾蘭商普羅帝納生物科學公司 | 識別ｔａｕ之抗體 |
| CN117534750B (zh) * | 2023-10-16 | 2024-06-11 | 遵义医科大学珠海校区 | 一种抗新型冠状病毒核衣壳蛋白的抗体或其抗原结合片段及其应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| CA1339198C (en) * | 1988-02-12 | 1997-08-05 | Gregory Paul Winter | Antibodies to the antigen campath-1 |
| GB9022547D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Purified immunoglobulin |
| GB9603507D0 (en) * | 1996-02-20 | 1996-04-17 | Isis Innovation | Antibody variants |
| GB9712892D0 (en) | 1997-06-20 | 1997-08-20 | Eclagen Ltd | Identification of mhc binding peptides |
| JP4334866B2 (ja) * | 2000-10-09 | 2009-09-30 | アイシス イノヴェイション リミテッド | 治療用抗体 |
| CA2832136C (en) * | 2002-09-27 | 2015-11-17 | Xencor | Optimized fc variants and methods for their generation |
| CN1225480C (zh) * | 2002-12-18 | 2005-11-02 | 马菁 | 抗cd52单克隆抗体、其编码序列及应用 |
| EP1694706B1 (en) * | 2003-11-01 | 2012-04-04 | Merck Patent GmbH | Modified anti-cd52 antibody |
| WO2005062893A2 (en) * | 2003-12-22 | 2005-07-14 | Genzyme Corporation | Anti-cd52 antibody treatment for diabetes |
| CA2596833C (en) | 2005-02-03 | 2016-04-12 | Antitope Limited | Human antibodies and proteins |
| CN101238150A (zh) * | 2005-05-24 | 2008-08-06 | 阿维斯塔金格兰技术有限公司 | 用于治疗慢性淋巴细胞性白血病的抗cd52单克隆抗体的重组生产方法 |
| MX2011012047A (es) | 2009-05-13 | 2011-12-14 | Genzyme Corp | Inmunoglobulinas humanas anti-cd52. |
| CN102079787A (zh) * | 2010-12-09 | 2011-06-01 | 协和干细胞基因工程有限公司 | 抗人cd52的工程抗体、载体、试剂盒及其用途 |
-
2011
- 2011-06-01 GB GBGB1109238.4A patent/GB201109238D0/en not_active Ceased
-
2012
- 2012-06-01 KR KR1020137034842A patent/KR20140036274A/ko not_active Abandoned
- 2012-06-01 BR BR112013030875A patent/BR112013030875A2/pt not_active IP Right Cessation
- 2012-06-01 US US14/123,349 patent/US9321841B2/en active Active
- 2012-06-01 JP JP2014513202A patent/JP6254522B2/ja active Active
- 2012-06-01 CA CA2837965A patent/CA2837965A1/en not_active Abandoned
- 2012-06-01 MY MYPI2013004327A patent/MY163257A/en unknown
- 2012-06-01 CN CN201280033384.6A patent/CN103649122B/zh active Active
- 2012-06-01 WO PCT/EP2012/060345 patent/WO2012164063A1/en not_active Ceased
- 2012-06-01 AU AU2012264643A patent/AU2012264643B2/en active Active
- 2012-06-01 RU RU2013158454/10A patent/RU2605307C2/ru active
- 2012-06-01 MX MX2013014083A patent/MX342676B/es active IP Right Grant
- 2012-06-01 SG SG2013085477A patent/SG195042A1/en unknown
- 2012-06-01 EP EP12727814.1A patent/EP2714739A1/en active Pending
-
2013
- 2013-11-26 ZA ZA2013/08900A patent/ZA201308900B/en unknown
- 2013-11-28 IL IL229713A patent/IL229713A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112574307B (zh) | 抗人Claudin18.2抗体及其应用 | |
| RU2013158454A (ru) | Гуманизированные антитела к сd52 | |
| JP2020522261A5 (enExample) | ||
| JP2014512809A5 (enExample) | ||
| US9771424B2 (en) | ICOS binding proteins | |
| TWI613217B (zh) | Ｉｌ－１８結合分子 | |
| RU2013145243A (ru) | Гуманизированные антитела к ctla4 | |
| JP2021500916A5 (enExample) | ||
| CN109651507B (zh) | 一种激动型4-1bb单克隆抗体 | |
| CN103172738A (zh) | Il-12/p40结合蛋白 | |
| CN109379892A (zh) | 抗-IgE抗体 | |
| JP2015534982A5 (enExample) | ||
| ME02678B (me) | Antitijela na ox-40 i postupci njihove primjene | |
| RU2014151788A (ru) | Молекула, специфически связывающаяся с rsv | |
| EP2928919A2 (en) | Blood-brain barrier (bbb) penetrating dual specific binding proteins | |
| JP2025501206A (ja) | Ｇｐｒｃ５ｄ抗体及びその応用 | |
| Teng et al. | SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination | |
| WO2021052465A1 (zh) | 抗人cd38抗体及其应用 | |
| CN110494447A (zh) | 使用抗人gpv1抗体抑制血小板聚集 | |
| US20210317405A1 (en) | Methods for the production of therapeutic, diagnostic, or research antibodies | |
| JP2020521752A (ja) | グロボｈに対するヒト化抗体および癌治療におけるその使用 | |
| CN113912720A (zh) | 一种抗人bcma单克隆抗体及应用 | |
| Zhu | Identification and Characterization of PF4/Heparin Reactive Antibodies in Heparin-Induce Thrombocytopenia Patients and COVID-19 Patients | |
| RU2024107254A (ru) | Модифицированное антитело против vegfr2 (kdr) и его применение | |
| Zhou et al. | Directed evolution of a stem-helix–targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity |